Consultation· 01
A dedicated team for clinicians navigating a complex field. We present what’s known across a wide range of subjects — and where the evidence stops short. Clinical and regulatory decisions stay with you.
Four disciplines
Provenance.
The Meridian approach
One resource.
One resource.
Four disciplines.
A quieter, more coherent experience — bringing research, regulatory context, sourcing, and consultation into one clinician-centered system.
Research· 02
Studies and publications compiled on request and sent to you directly — the papers themselves, with the authors’ own stated outcomes and limitations. Unfavorable findings are included on the same terms. The conclusions stay yours.
Regulatory· 03
Current information on how the regulatory layers stack, across countries and within the US. Nothing has drawn more questions this year than the new state laws: what they reach, and what’s next.
Sourcing· 04
A disciplined view of provenance. Collaboration with FDA-registered U.S. labs that provide documentation on products. Registration is where qualification starts, not where it ends.
Meridian Biologics sources products from tissue establishments that maintain current FDA registration and that are reviewed through Meridian Biologics’ supplier qualification process.
The long view
Depth of experience.
Depth of experience.
Breadth of options.
Two things every clinician deserves in one place: seasoned perspective, and a clear-eyed view of an evolving field — its possibilities and its limits.
Industry expertise
Experience that makes complexity legible.
A clinician-centric team with deep tenure in this field — command of its standards, its sourcing, and its regulatory landscape. That command is kept current as all three evolve, so the perspective you draw on is never yesterday’s.
A broader view of the field
The whole field, in clearer view.
A curated breadth of emerging therapies and evolving science — the wider view of a field that is growing. Every option is distilled and presented on the same terms: what’s known, what’s still emerging, and where the evidence stops short.
The Landscape
A fast-moving field rewards informed navigation.
The challenge
Regenerative therapies are advancing rapidly, and clinical interest continues to grow. Yet the path from innovation to responsible use is not always straightforward. The process varies by country. In the US, there's a national baseline, with a growing number of states enacting their own legislation. That's a lot to track alongside a full practice.
Our approach
Meridian Biologics helps clinicians approach regenerative therapy through a more informed and responsible lens. From educational resources to provenance-led sourcing support, we compile published literature when you request it and help you approach this evolving field with the structure and perspective today's clinical environment requires.
In practice
A more structured, transparent path for the decisions you face — sound provenance, current research, and vetted sources you can rely on. A resource that stays current as the field moves, sustainable for your practice.